Cabozantinib Suppliers & Bulk Manufacturers
Available Forms: Tablets / Capsules
Available Strengths: 20 mg, 40 mg, 60 mg, 80mg, 100mg
Reference Brands: Cometriq (USA), Cabometyx (USA/EU)
Category:
Oncology Cancer Care
Cabozantinib is an oral tyrosine kinase inhibitor that targets multiple receptors involved in tumor growth, angiogenesis, and metastasis. It is used in the treatment of advanced cancers, including renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), medullary thyroid cancer (MTC), differentiated thyroid cancer (DTC), and neuroendocrine tumors (NETs). Cabozantinib helps slow tumor progression and improve patient outcomes by inhibiting pathways critical for cancer cell survival and proliferation.
Cabozantinib is available in Tablets / Capsules
and strengths such as 20 mg, 40 mg, 60 mg, 80mg, 100mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cabozantinib is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cabozantinib can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing